4
Changes in Ownership
ARS Pharmaceuticals, Inc. Filed Acc 0001193805-24-001348
10% owner sold 563,270 shares at an average $18.01 ($10,143,706)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Flynn James E 10% owner | 2024-11-11 | Sale | −40,596 | $17.45 | $708,400 | 5,498,368 | I |
| Flynn James E 10% owner | 2024-11-11 | Sale | −40,596 | $17.45 | $708,400 | 5,498,367 | I |
| Flynn James E 10% owner | 2024-11-11 | Sale | −223,632 | $18.15 | $4,058,921 | 5,274,736 | I |
| Flynn James E 10% owner | 2024-11-11 | Sale | −223,632 | $18.15 | $4,058,921 | 5,274,735 | I |
| Flynn James E 10% owner | 2024-11-12 | Sale | −7,853 | $17.16 | $134,757 | 5,266,883 | I |
| Flynn James E 10% owner | 2024-11-12 | Sale | −7,854 | $17.16 | $134,775 | 5,266,881 | I |
| Flynn James E 10% owner | 2024-11-12 | Sale | −9,554 | $17.77 | $169,775 | 5,257,329 | I |
| Flynn James E 10% owner | 2024-11-12 | Sale | −9,553 | $17.77 | $169,757 | 5,257,328 | I |
| Open-market sales · 563,270 sh · avg $18.01 · $10,143,706 | |||||||
Loading xslF345X05/e664025_4-arsp.xml…